Prestige Consumer Healthcare (PBH) Current Leases (2019 - 2025)
Prestige Consumer Healthcare's (PBH) quarterly Current Leases came in at $2.6 million in Q4 2025, down 56.56% year-on-year from $6.0 million in Q4 2024, and up 1.63% quarter-over-quarter from $2.6 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Current Leases (2019 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Current Leases history runs 7 years deep, the most recent figure standing at $2.6 million for Q4 2025.
- On a quarterly basis, Current Leases fell 56.56% year-over-year to $2.6 million in Q4 2025; TTM through Dec 2025 was $2.6 million, a 56.56% decrease from a year earlier, with the FY2025 full-year figure at $6.0 million, up 29.82% from the prior year.
- Current Leases improved to $2.6 million in Q4 2025 per PBH's latest filing, from $2.6 million in the prior quarter.
- Across five years, Current Leases topped out at $6.9 million in Q4 2022 and bottomed at $91000.0 in Q3 2024.
- The 5-year median for Current Leases is $3.3 million (2023), against an average of $4.1 million.
- Across the five-year window, Current Leases tumbled 98.65% in 2024 and jumped 2726.37% in 2025, its largest moves.
- Year by year, Current Leases stood at $2.6 million in 2021, then jumped by 159.18% to $6.9 million in 2022, then dropped by 17.61% to $5.6 million in 2023, then rose by 6.51% to $6.0 million in 2024, then sank by 56.56% to $2.6 million in 2025.
- Per Business Quant, the three latest PBH Current Leases figures stand at $2.6 million (Q4 2025), $2.6 million (Q3 2025), and $2.5 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn | 2.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.61 Mn |
| Sep 30, 2025 | 2.57 Mn |
| Jun 30, 2025 | 2.53 Mn |
| Mar 31, 2025 | 6.05 Mn |
| Dec 31, 2024 | 6.02 Mn |
| Sep 30, 2024 | 91,000.00 |
| Jun 30, 2024 | 3.65 Mn |
| Mar 31, 2024 | 4.66 Mn |
| Dec 31, 2023 | 5.65 Mn |
| Sep 30, 2023 | 6.73 Mn |
| Jun 30, 2023 | 2.86 Mn |
| Mar 31, 2023 | 2.83 Mn |
| Dec 31, 2022 | 6.86 Mn |
| Sep 30, 2022 | 2.79 Mn |
| Jun 30, 2022 | 6.55 Mn |
| Mar 31, 2022 | 2.75 Mn |
| Dec 31, 2021 | 2.65 Mn |
| Sep 30, 2021 | 2.63 Mn |
| Jun 30, 2021 | 5.97 Mn |
| Mar 31, 2021 | 5.86 Mn |